Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Axogen (AXGN) management is scheduled to participate in three upcoming investor conferences, with appearances beginning on November 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Axogen (AXGN) management is scheduled to participate in three upcoming investor conferences, with appearances beginning on November 11, 2026.
Fireside chats are scheduled for the Canaccord Genuity forum on November 11 at 10:00 AM ET and Jefferies conference in London on November 17 at 8:30 AM ET. A Piper Sandler presentation is scheduled for December 2 at 8:00 AM ET. Each event includes one-on-one investor meetings.
Details
News Market Reaction – AXGN
On Nov 3, the day this news came out, AXGN closed 0.70% below the previous close. Argus tracked a peak move of +2.4% during that session. Our momentum scanner recorded 28 alerts in the available session data.
Data tracked by StockTitan Argus for the Nov 3 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALACHUA, Fla. and TAMPA, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in three upcoming investor conferences:
Canaccord Genuity 20th Annual MedTech, Diagnostics, Digital Health & Services Forum
Participation: Fireside Chat and 1x1 investor meetings
Date/Time: Fireside Chat Wednesday, November 11, 2026, 10:00 AM ET
Jefferies Global Healthcare Conference in London
Participation: Fireside Chat and 1x1 investor meetings
Date/Time: Fireside Chat Tuesday, November 17, 2026, 8:30 AM ET
Piper Sandler 38th Annual Healthcare Conference
Participation: Presentation and 1x1 investor meetings
Date/Time: Presentation Wednesday, December 2, 2026, 8:00 AM ET
Webcast events can be accessed live through the Investors page at www.axogeninc.com. For those unable to listen to the live broadcast, the replay will be archived for 90 days and available on the Investors page at www.axogeninc.com.
About Axogen
Axogen (Nasdaq: AXGN) is focused on the science, development and commercialization of technologies for peripheral nerve repair. With a mission to make nerve repair the expected standard of care, Axogen advances the field through research, education, and collaboration with surgeons and healthcare providers across a global network.
Axogen’s product portfolio includes Avance® (acellular nerve allograft-arwx), Avance® Nerve Graft, Axoguard Nerve Connector®, Axoguard Nerve Protector®, Axoguard HA+ Nerve Protector™, Axoguard Nerve Cap®, Avive+ Soft Tissue Matrix™, and NerveTape®.
Contact:
Axogen, Inc.
InvestorRelations@axogeninc.com
